8-K: ModivCare Reports Q1 2025 Financial Results Amidst Nasdaq Listing Concerns

ModivCare's Q1 2025 results show a revenue decrease and net loss, alongside a Nasdaq notification regarding its market value of publicly held shares falling below the required threshold.

Summary

• ModivCare reported a service revenue of $650.7 million for Q1 2025, a 4.9% decrease year-over-year.
• The company experienced a net loss of $50.4 million, or negative $3.52 per diluted common share.
• Adjusted EBITDA was $32.6 million, representing 5.0% of service revenue.
• ModivCare executed $105.0 million in new financing to support transformation efforts.
• Targeted cost reduction actions are expected to generate over $20.0 million in annualized G&A savings.
• The company received a notification from Nasdaq that its market value of publicly held shares (MVPHS) fell below the $15 million threshold required for continued listing.
• ModivCare has until November 1, 2025, to regain compliance with the MVPHS requirement.
• NEMT revenue was $449.0 million, down 6.3% year-over-year, with a 3.9% net income margin and a 6.2% Adjusted EBITDA margin.
• PCS revenue was $181.8 million, down 1.0%, with net income of $2.4 million and an Adjusted EBITDA of $12.2 million.
• Monitoring revenue was $18.1 million, down 9.8%, with a 6.0% net loss margin and a 28.8% Adjusted EBITDA margin.
• Net contract receivables increased to $108.5 million, up from $95.2 million last quarter.
• Operating cash flow was a use of $82.1 million and Free cash flow was negative $86.2 million.
• Modivcare ended the quarter with $116.0 million in cash and remained fully drawn on its revolver.

Sentiment

Score: 4

Explanation: The sentiment is negative due to the revenue decline, net loss, Nasdaq listing concerns, and negative cash flow, although management expresses optimism about future performance.

Positives

• ModivCare executed $105.0 million in new financing to support transformation efforts.
• Targeted cost reduction actions are expected to generate greater than $20.0 million in annualized G&A savings.
• PCS revenue was $181.8 million, down 1.0%, with net income of $2.4 million and an Adjusted EBITDA of $12.2 million up 8.5% year-over-year.
• NEMT Adjusted EBITDA margin up 50 basis points.

Negatives

• Service revenue decreased by 4.9% year-over-year to $650.7 million.
• The company reported a net loss of $50.4 million, or $3.52 per diluted share.
• ModivCare received a Nasdaq notification due to its market value of publicly held shares falling below $15 million.
• Operating cash flow was a use of $82.1 million and Free cash flow was negative $86.2 million.
• Modivcare ended the quarter with $116.0 million in cash and remained fully drawn on its revolver.

Risks

• The company's failure to regain compliance with Nasdaq listing requirements could lead to delisting.
• Contract attrition in the NEMT segment and lower volumes in PCS and Monitoring contributed to revenue decline.
• Negative operating and free cash flow indicate potential liquidity concerns.
• The company is fully drawn on its revolver, indicating reliance on debt financing.
• The company has substantial doubt about our ability to meet our obligations as they come due within one year from the date of issuance of the financial statements for fiscal year 2024.

Future Outlook

The company intends to monitor its MVPHS and may consider implementing available options to regain compliance with the Nasdaq requirement; targeted cost reduction actions expected to generate greater than $20.0 million in annualized G&A savings.

Management Comments

• L. Heath Sampson, President and CEO, stated that the company continued to advance its strategic objectives and operational initiatives in Q1.
• L. Heath Sampson noted that company-wide alignment on key initiatives positions Modivcare to deliver enhanced performance and long-term value.

Industry Context

ModivCare operates in the technology-enabled healthcare services sector, providing non-emergency medical transportation (NEMT), personal care services (PCS), and in-home monitoring solutions; the company's performance is influenced by factors such as government and private insurance program funding, reimbursement rates, and competition in the marketplace.

Comparison to Industry Standards

• It is difficult to compare ModivCare's results directly to industry standards without specific competitor data.
• However, companies like American Medical Response (AMR) and Global Medical Response (GMR) in the NEMT sector, and Addus HomeCare and LHC Group in the PCS sector, could be considered for benchmarking purposes.
• ModivCare's Adjusted EBITDA margin of 5.0% should be compared to the margins of these companies to assess its relative profitability.
• The decline in revenue and net loss should be evaluated against industry trends and the performance of similar companies.

Stakeholder Impact

• Shareholders face the risk of delisting if the company fails to regain compliance with Nasdaq requirements.
• Employees may be affected by cost reduction actions and organizational consolidation.
• Customers and members may experience changes in service delivery as the company focuses on strategic initiatives.
• Payors may be impacted by changes in reimbursement rates and contract terms.
• Creditors are exposed to increased risk due to the company's reliance on debt financing and negative cash flow.

Next Steps

• The company intends to monitor its MVPHS and may consider implementing available options to regain compliance with the Nasdaq requirement.
• ModivCare will focus on securing new contracts, laying the groundwork for scalable automation, reducing G&A, strengthening working-capital discipline, and progressing toward divestiture readiness.

Key Dates

Keywords

ModivCare, financial results, NEMT, PCS, monitoring, Nasdaq, MVPHS, EBITDA, revenue, net loss